ArticleCancer cell international2025
MiR-668-3p in M2 macrophage-derived exosomes activates autophagy through the ETS1/EGFR axis and promotes cisplatin resistance in gastric cancer.
Article in Cancer cell international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundPrevious research suggests that tumor-associated macrophages (TAMs) influence the cisplatin (DDP) tolerance of gastric cancer (GC) cells via the secretion of microRNA-containing exosomes. This study aims to investigate the role of exosomal miR-668-3p from M2 macrophages in modulating DDP resistance, using both in vitro and in vivo models to provide a comprehensive analysis. MATERIALS AND
methodsThe expression profiles of DDP-resistant GC tissues were assessed through microarray, while immunofluorescence confirmed the uptake of these exosomes by GC cells. The role of miR-668-3p in regulating DDP resistance was explored using CCK8 assays, colony formation, EDU incorporation, and Western blotting. The interaction between miR-668-3p and ETS1 was validated through RIP and RNA pull-down assays. Furthermore, the regulatory role of the miR-668-3p/ETS1/EGFR axis in autophagy and DDP resistance was examined in GC cell lines and a tumor xenograft model.
resultsmiR-668-3p was significantly upregulated in DDP-resistant GC tissues. Exosomes originating from M2 macrophages transfer miR-668-3p to GC cells, enhancing their DDP resistance. Additionally, miR-668-3p was found to bind to ETS1 mRNA, leading to its suppression and a consequent decrease in EGFR expression. This reduction in EGFR expression was closely linked to the activation of autophagy, further augmenting DDP resistance in GC cells.
conclusionM2 macrophage-derived exosomal miR-668-3p promotes DDP resistance in GC cells by targeting the ETS1/EGFR axis, thereby activating the autophagy pathway. Future research should focus on developing targeted inhibition strategies for miR-668-3p to effectively reverse DDP resistance in GC cells, optimizing its potential for clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.